RegWardenFDA facility compliance records
Recall

Class II — CHANGE HEALTHCARE CANADA COMPANY

Recalling firmChange Healthcare Canada Company
Registered facilityCHANGE HEALTHCARE CANADA COMPANY (the firm's only registered facility)
ClassificationClass II
StatusOngoing
ReasonA potential issue has been identified in Change Healthcare Cardiology Hemo where incorrect data entry can lead to inaccurate hemodynamic calculations, potentially resulting in misdiagnosis and inappropriate treatment. This issue occurs when the unit of measurement (UOM) for hemoglobin is configured in a way that differs from the users understanding.
ProductChange Healthcare Cardiology Hemo. Versions 14.2, 14.1.1, 14.2, 14.3, 14.3.2, 14.3, 15.0.1, 15.1.
Quantity221 systems
DistributionWorldwide distribution - US Nationwide and the countries of Australia, Canada, Germany, Ireland, Israel, United Kingdom.
Initiated2024-08-21
Classified2024-10-17
Recall numberZ-0126-2025
InitiationVoluntary: Firm initiated

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Class II recall — CHANGE HEALTHCARE CANADA COMPANY (Z-0126-2025).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/95284/

Not open yet

Alerts for Change Healthcare Canada Company

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.